A randomized, single dose, 3-period crossover study to evaluate the dosage form proportionality, dose proportionality and pharmacokinetics of mometasone furoate and formoterol fumarate from three combination MDI [metered-dose inhaler] formulations
Phase of Trial: Phase I
Latest Information Update: 07 Oct 2008
At a glance
- Drugs Mometasone/formoterol (Primary)
- Indications Allergic asthma; Asthma; Chronic obstructive pulmonary disease
- Focus Pharmacokinetics
- Sponsors Novartis
- 07 Oct 2008 Results reported at the Annual Congress of the European Respiratory Society.
- 21 Jun 2007 Status change from in progress to completed
- 18 Jan 2007 New trial record.